VP of Research and Special Initiatives, Google
Founder and CEO, Lighter Capital
Professor, Michigan State University
Serial Entrepreneur and Investor
Founder and Managing Director of DEV
Founder and CEO of Brooks Bell Inc.
CEO of Foundry
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Rare and genetic diseases affect one in 10 Americans, 30 million people in the United States, and 300 million people globally. Over 6,800 distinct rare diseases exist, with about 80 percent caused by faulty genes. Understanding the regulatory pathway and unique statistical approaches for orphan drug products are critical to a well-designed drug development program. More information and online registration is here.